Promising active substance against hepatitis E identified

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a ...
Gastroenterology Advisor

FDA Drug Approval Decisions Expected in April 2026

Treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity are under review.
Scientific Research Publishing

Weight Gain Following Dolutegravir Based Antiretroviral Therapy in HIV-Naive Patients: A Comparative Study at the Ambulatory Treatment Center of the Regional Hospital of ...

1 Service des Maladies Infectieuses et Tropicales (SMIT), Fann University Hospital, Dakar, Senegal. 2 Department of Infectious and Tropical Diseases, Dalal Jamm Hospital, Dakar, Senegal. In Senegal, ...
C&EN

Identification and Characterization of a Secondary Sodium-Binding Site and the Main Selectivity Determinants in the Human Concentrative Nucleoside Transporter 3

† Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia and Institute of Biomedicine (IBUB), Universitat de Barcelona, 08028 Barcelona, Spain ‡ Oncology Program, National Biomedical ...